211 related articles for article (PubMed ID: 31753260)
1. Cost-Effectiveness of Cancer Screening: Health and Costs in Life Years Gained.
Ratushnyak S; Hoogendoorn M; van Baal PHM
Am J Prev Med; 2019 Dec; 57(6):792-799. PubMed ID: 31753260
[TBL] [Abstract][Full Text] [Related]
2. [Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].
Shi JF; Mao AY; Bai YN; Liu GX; Liu CC; Wang H; Cao MM; Feng H; Wang L; Bai FZ; Huang HY; Bai HJ; Zhu J; Yan XX; Zhang J; Ren JS; Li N; Dai M; Chen WQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):306-313. PubMed ID: 32187937
[No Abstract] [Full Text] [Related]
3. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
[TBL] [Abstract][Full Text] [Related]
4. Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic Review.
Mohan G; Chattopadhyay SK; Ekwueme DU; Sabatino SA; Okasako-Schmucker DL; Peng Y; Mercer SL; Thota AB;
Am J Prev Med; 2019 Oct; 57(4):557-567. PubMed ID: 31477431
[TBL] [Abstract][Full Text] [Related]
5. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
7. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
8. Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy.
Veronesi G; Navone N; Novellis P; Dieci E; Toschi L; Velutti L; Solinas M; Vanni E; Alloisio M; Ghislandi S
Lung Cancer; 2020 May; 143():73-79. PubMed ID: 32234647
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
Heijnsdijk EA; de Carvalho TM; Auvinen A; Zappa M; Nelen V; Kwiatkowski M; Villers A; Páez A; Moss SM; Tammela TL; Recker F; Denis L; Carlsson SV; Wever EM; Bangma CH; Schröder FH; Roobol MJ; Hugosson J; de Koning HJ
J Natl Cancer Inst; 2015 Jan; 107(1):366. PubMed ID: 25505238
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Current Colorectal Cancer Screening Tests.
Ladabaum U
Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):479-497. PubMed ID: 32439083
[TBL] [Abstract][Full Text] [Related]
12. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Tsiachristas A; Gittins M; Kitchener H; Gray A
J Med Screen; 2018 Jun; 25(2):99-109. PubMed ID: 28530515
[TBL] [Abstract][Full Text] [Related]
14. [Economic evaluation of fifteen cervical cancer screening strategies in rural China].
Wang YY; Wang ZJ; Zhang Y; Gao XH; Yang CX; Zhao FH; Qiao YL; Ma L; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2019 Dec; 54(12):840-847. PubMed ID: 31874474
[No Abstract] [Full Text] [Related]
15. Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
Omidvari AH; Lansdorp-Vogelaar I; de Koning HJ; Meester RGS
PLoS One; 2021; 16(7):e0253893. PubMed ID: 34252090
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
Rim SH; Allaire BT; Ekwueme DU; Miller JW; Subramanian S; Hall IJ; Hoerger TJ
Cancer Causes Control; 2019 Aug; 30(8):819-826. PubMed ID: 31098856
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.
Goldie SJ; Kuntz KM; Weinstein MC; Freedberg KA; Palefsky JM
Am J Med; 2000 Jun; 108(8):634-41. PubMed ID: 10856411
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening the average-risk population for colorectal cancer.
Provenzale D
Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
[TBL] [Abstract][Full Text] [Related]
19. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
